253
Participants
Start Date
September 30, 2012
Primary Completion Date
November 30, 2012
Study Completion Date
December 31, 2012
Hyaluronidase
Subjects received intradermal injections of 0.02 mL Amphadase® (hyaluronidase 150 USP units/mL) at two random sites on their forearms.
Histamine
Subjects received one intradermal injection of 0.02 mL Histatrol® (histamine base 0.1 mg/mL) at one random sites on their forearms.
Saline
Subjects received one intradermal injection of 0.02 mL saline at one random site on their forearm.
Amphastar Site 0023, Lake Oswego
Amphastar Site 0026, Portland
Amphastar Site 0022, Eugene
Amphastar Site 0038, Renton
Amphastar Site 0034, Seattle
Lead Sponsor
Amphastar Pharmaceuticals, Inc.
INDUSTRY